[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CR20110533A - Compuesto de pirazol - Google Patents

Compuesto de pirazol

Info

Publication number
CR20110533A
CR20110533A CR20110533A CR20110533A CR20110533A CR 20110533 A CR20110533 A CR 20110533A CR 20110533 A CR20110533 A CR 20110533A CR 20110533 A CR20110533 A CR 20110533A CR 20110533 A CR20110533 A CR 20110533A
Authority
CR
Costa Rica
Prior art keywords
compound
pirazol
secretion
tumor
exhibits
Prior art date
Application number
CR20110533A
Other languages
English (en)
Inventor
Nishida Haruyuki
Fujimori Ikuo
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of CR20110533A publication Critical patent/CR20110533A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención proporciona un compuesto que tiene una excelente accion supresora de la secreción de un ácido, y que exhibe una actividad anti-tumoral y otras.
CR20110533A 2009-03-26 2011-10-12 Compuesto de pirazol CR20110533A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2009077078 2009-03-26

Publications (1)

Publication Number Publication Date
CR20110533A true CR20110533A (es) 2012-02-13

Family

ID=42781069

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110533A CR20110533A (es) 2009-03-26 2011-10-12 Compuesto de pirazol

Country Status (25)

Country Link
US (1) US8895588B2 (es)
EP (1) EP2412713B1 (es)
JP (1) JP5552481B2 (es)
KR (1) KR101656906B1 (es)
CN (1) CN102448953B (es)
AU (1) AU2010228220B2 (es)
BR (1) BRPI1009090A2 (es)
CA (1) CA2756086A1 (es)
CL (1) CL2011002351A1 (es)
CO (1) CO6460700A2 (es)
CR (1) CR20110533A (es)
DO (1) DOP2011000296A (es)
EA (1) EA019853B1 (es)
EC (1) ECSP11011419A (es)
GE (1) GEP20156222B (es)
IL (1) IL215235A (es)
MA (1) MA33214B1 (es)
MX (1) MX2011009943A (es)
NZ (1) NZ595890A (es)
PE (1) PE20120618A1 (es)
SG (1) SG174476A1 (es)
TN (1) TN2011000474A1 (es)
UA (1) UA107457C2 (es)
WO (1) WO2010110378A1 (es)
ZA (1) ZA201107435B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110917130A (zh) 2012-06-27 2020-03-27 武田药品工业株式会社 用盐稳定的胺和有机酸的液体制剂
CN105072909A (zh) * 2012-09-27 2015-11-18 阿莱塔纳治疗学股份有限公司 应用控制食欲不振的化合物的组合物和方法
CN109200268A (zh) 2015-01-28 2019-01-15 阿莱塔纳治疗学股份有限公司 增重化合物的组合物及其长期使用方法
CN105067814A (zh) * 2015-07-24 2015-11-18 中国科学院成都生物研究所 解旋酶水解atp活性测定方法
US11767311B2 (en) * 2020-06-17 2023-09-26 Ildong Pharmaceutical Co., Ltd. Acid secretion inhibitor and use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3285991A (en) 1963-03-26 1966-11-15 Union Carbide Corp Polyepoxides cured with the reaction product of a dihydroxydiphenylsul-fone, an amine, and an aldehyde
US4847289A (en) 1987-06-08 1989-07-11 Merck & Co., Inc. Thiophene sulfonamide antiglaucoma agents
MX9205392A (es) 1991-10-29 1993-04-01 Du Pont Triazolcarbozamidas herbicidas y procedimiento para su obtencion.
EP0786455B1 (en) 1994-09-26 2003-12-03 Shionogi & Co., Ltd. Imidazole derivative
JPH0948778A (ja) 1995-08-04 1997-02-18 Sagami Chem Res Center ２−置換−３−アルコキシ−５−（ピロール−２−イル）フラン誘導体
CA2235986C (en) 1995-11-06 2006-09-12 University Of Pittsburgh Inhibitors of protein isoprenyl transferases
SK86699A3 (en) 1996-12-23 2000-11-07 Du Pont Pharm Co Nitrogen containing heteroaromatics as factor xa inhibitors
WO1999042461A1 (en) 1998-02-23 1999-08-26 Warner-Lambert Company Substituted quinoxaline derivatives as interleukin-8 receptor antagonists
CA2493618A1 (en) 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
US7417152B2 (en) 2003-05-02 2008-08-26 Elan Pharmaceuticals, Inc. 4-bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid amide derivatives and related compounds as bradykinin B1 receptor antagonists for the treatment of inflammatory diseases
DE602004029355D1 (de) 2003-05-26 2010-11-11 Takeda Pharmaceutical Sulfopyrrolderivate
CA2532800C (en) 2003-07-23 2013-06-18 Exelixis, Inc. Anaplastic lymphoma kinase modulators and methods of use
WO2006036024A1 (ja) 2004-09-30 2006-04-06 Takeda Pharmaceutical Company Limited プロトンポンプ阻害薬
JO2791B1 (en) * 2005-08-30 2014-03-15 تاكيدا فارماسويتيكال كمبني ليمتد Acid secretion inhibitor
WO2007114338A1 (ja) 2006-03-31 2007-10-11 Takeda Pharmaceutical Company Limited 酸分泌抑制薬
US8933105B2 (en) * 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
JP2009077078A (ja) 2007-09-19 2009-04-09 Brother Ind Ltd 位置検出システム
US20090156642A1 (en) 2007-09-28 2009-06-18 Takeda Pharmaceutical Company Limited 5-Membered heterocyclic compound
WO2009041447A1 (ja) 2007-09-28 2009-04-02 Takeda Pharmaceutical Company Limited ５員複素環化合物
PE20091846A1 (es) 2008-05-19 2009-12-16 Plexxikon Inc DERIVADOS DE PIRROLO[2,3-d]-PIRIMIDINA COMO MODULADORES DE CINASAS
CA2731196A1 (en) 2008-07-18 2010-01-21 Takeda Pharmaceuticals Company Limited Benzazepine derivatives and their use as hstamine h3 antagonists

Also Published As

Publication number Publication date
BRPI1009090A2 (pt) 2016-03-01
UA107457C2 (uk) 2015-01-12
EP2412713A4 (en) 2014-04-02
EA201171168A1 (ru) 2012-05-30
ECSP11011419A (es) 2011-11-30
IL215235A0 (en) 2011-12-29
WO2010110378A1 (ja) 2010-09-30
TN2011000474A1 (en) 2013-03-27
JP5552481B2 (ja) 2014-07-16
GEP20156222B (en) 2015-01-26
CA2756086A1 (en) 2010-09-30
EP2412713B1 (en) 2016-11-30
DOP2011000296A (es) 2011-10-15
NZ595890A (en) 2013-09-27
EA019853B1 (ru) 2014-06-30
CN102448953B (zh) 2014-05-07
US8895588B2 (en) 2014-11-25
US20120095057A1 (en) 2012-04-19
CL2011002351A1 (es) 2012-07-13
KR101656906B1 (ko) 2016-09-12
SG174476A1 (en) 2011-10-28
MA33214B1 (fr) 2012-04-02
EP2412713A1 (en) 2012-02-01
KR20110130483A (ko) 2011-12-05
CN102448953A (zh) 2012-05-09
IL215235A (en) 2014-07-31
JPWO2010110378A1 (ja) 2012-10-04
CO6460700A2 (es) 2012-06-15
AU2010228220A1 (en) 2011-11-17
PE20120618A1 (es) 2012-06-05
AU2010228220A2 (en) 2011-11-24
MX2011009943A (es) 2011-10-06
AU2010228220B2 (en) 2015-05-21
ZA201107435B (en) 2012-08-29

Similar Documents

Publication Publication Date Title
EA201270619A1 (ru) Применение бетанехола для лечения ксеростомии
MX356282B (es) Composiciones y metodos que comprenden variantes de proteasa.
UY34763A (es) Inhibidores de la agregación plaquetaria
UA104459C2 (uk) Антитіла проти fgfr3 і способи їх застосування
UY34342A (es) ?derivados de pirrolopirimidina y purina?.
ES2530730T3 (es) Complejo hidrohalogenuro-agomelatina y preparación del mismo
UY4151Q (es) Vincha con auriculares
MX2013001473A (es) Anticuerpos contra il-18r1 y usos de los mismos.
MX368288B (es) Una combinación de anticuerpos anti-cd38 y melfalán para usarse en el tratamiento de mieloma múltiple.
MX2012011829A (es) Anticuerpos de anti-poliubiquitina y metodos de uso.
MX2012007379A (es) Anticuerpos anti-bv8 y usos de los mismos.
EA201400940A1 (ru) Способ получения медетомидина
CR20110533A (es) Compuesto de pirazol
GT201300041A (es) Composicion fungicida sinergista
CL2009001973S1 (es) Mostrador.
CR20140296A (es) Dispositivo de Reducción activa de interferencia-ruido y un método relacionado con el mismo
RU2010119316A (ru) Поли - n, n- диаллиламиноэтановая кислота
IT1396316B1 (it) Proiettore ad ampia diffusione con sorgenti leds precollimate.
RU2009122188A (ru) Средство, повышающее противоопухолевый эффект метотрексата
RU2009100631A (ru) 2-гидрокси-4-оксо-4-фенил-2-бутеноат бензотиазолиламмония, обладающий гипогликемической активностью
UY33207A (es) Métodos de preparación de tiazolidinas
RU2011116802A (ru) 1-(1-адамантил)-4-нитрозопиразолы
PA8849101A1 (es) Procedimiento de preparación del hemifumarato de eplivanserina
CL2009001553S1 (es) Mesa.
CL2009001552S1 (es) Mesa.